Related Experiment Video
Updated: Jun 1, 2026
09:06
Labeling hESCs and hMSCs with Iron Oxide Nanoparticles for Non-Invasive in vivo Tracking with MR Imaging
Published on: March 31, 2008
Labeling human embryonic stem-cell-derived cardiomyocytes for tracking with MR imaging
Rosalinda T Castaneda1, Sophie Boddington, Tobias D Henning
1Pediatric Radiology, Lucile Packard Children's Hospital, Stanford School of Medicine, Stanford, CA 94305-5654, USA. rcastan@stanford.edu
Pediatric Radiology
|May 20, 2011
Summary
Labeling human embryonic stem cell-derived cardiomyocytes (hESC-CM) before differentiation with superparamagnetic iron oxide nanoparticles (SPIO) enables effective MRI tracking. This method is crucial for monitoring transplanted cells and advancing pediatric cardiomyopathy treatments.
Area of Science:
- Regenerative Medicine
- Biomedical Imaging
- Stem Cell Biology
Background:
- Human embryonic stem cell-derived cardiomyocytes (hESC-CM) show promise for treating pediatric cardiomyopathies.
- Clinical application is hindered by cell loss and death post-transplantation.
- Noninvasive monitoring of transplanted hESC-CM is essential for improving therapeutic strategies.
Purpose of the Study:
- To develop a clinically applicable method for labeling hESC-CM using FDA-approved superparamagnetic iron oxide nanoparticles (SPIO).
- To evaluate the impact of labeling timing (pre- or post-differentiation) on SPIO uptake and MRI signal.
Main Methods:
- Human embryonic stem cells (hESC) were incubated with ferumoxides (SPIO) either before or after differentiation into cardiomyocytes (CM).
- Labeled hESC-CM were imaged using a 7T MR scanner with a T2-weighted multi-echo spin-echo sequence.
- Cell viability, iron uptake, and T2-relaxation times were quantitatively assessed and compared.
Main Results:
- hESC-CM labeled prior to differentiation exhibited significant magnetic resonance (MR) signal changes and substantial iron uptake.
- Cells labeled after differentiation showed minimal iron uptake and no significant alteration in MR signal.
- Cell morphology, differentiation efficiency, and viability remained consistent across all experimental groups.
Conclusions:
- Labeling hESC-CM before differentiation is critical for achieving a detectable MR signal using SPIO.
- This pre-differentiation labeling technique facilitates noninvasive monitoring of transplanted hESC-CM delivery and engraftment.
- The developed method holds potential for advancing stem cell-based therapies aimed at repairing damaged myocardium.
